These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34524660)

  • 1. Methods for Studying Mouse and Human Invariant Natural Killer T Cells.
    Zhou Y; Li YR; Zeng S; Yang L
    Methods Mol Biol; 2021; 2388():35-57. PubMed ID: 34524660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
    Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
    Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner.
    Pereira CS; Ribeiro H; Pérez-Cabezas B; Cardoso MT; Alegrete N; Gaspar A; Leão-Teles E; Macedo MF
    Mol Genet Metab; 2018 Sep; 125(1-2):161-167. PubMed ID: 30030044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
    Yang G; Artiaga BL; Lewis ST; Driver JP
    Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanized mouse model for
    Saavedra-Avila NA; Dellabona P; Casorati G; Veerapen N; Besra GS; Howell AR; Porcelli SA
    Front Immunol; 2022; 13():1011209. PubMed ID: 36263021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-glycosidic compounds can stimulate both human and mouse iNKT cells.
    Jukes JP; Gileadi U; Ghadbane H; Yu TF; Shepherd D; Cox LR; Besra GS; Cerundolo V
    Eur J Immunol; 2016 May; 46(5):1224-34. PubMed ID: 26873393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
    Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
    J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel in vitro invariant natural killer T cell functional assays.
    Balasko A; Graydon C; Fowke KR
    J Immunol Methods; 2021 Dec; 499():113171. PubMed ID: 34706265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
    Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
    Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
    Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells.
    Smith DJ; Liu S; Ji S; Li B; McLaughlin J; Cheng D; Witte ON; Yang L
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1523-8. PubMed ID: 25605948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy.
    Kharkwal SS; Johndrow CT; Veerapen N; Kharkwal H; Saavedra-Avila NA; Carreño LJ; Rothberg S; Zhang J; Garforth SJ; Jervis PJ; Zhang L; Donda A; Besra AK; Cox LR; Almo SC; Howell A; Evans EE; Zauderer M; Besra GS; Porcelli SA
    Cancer Res; 2021 Apr; 81(7):1788-1801. PubMed ID: 33483371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.